Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.

Background: Melasma is one of the most common cosmetic disorders with skin darkening. Although several treatment modalities are available, none is satisfactorily used in management of this condition. Tranexamic acid (TA), a plasmin inhibitor, is reported to improve melasma when injected locally or used as oral and topical forms.